Achieving ventricular rate control in patients taking chronic beta-blocker therapy
The American Journal of Emergency Medicine Sep 15, 2017
Feeney ME, et al. - The authors assessed the difference in response to ventricular rate control with intravenous (IV) metoprolol compared to IV diltiazem in patients taking chronic beta-blocker therapy who present to the emergency department (ED) in atrial fibrillation (AF) with rapid ventricular rate (RVR). In patients in AF with RVR on chronic beta-blocker therapy, the use of IV diltiazem was correlated with a higher rate of successful response to rate control compared to IV metoprolol. However, the difference between groups was not statistically significant.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries